Cargando…
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium
To mitigate the massive COVID-19 burden caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), several vaccination campaigns were initiated. We performed a single-center observational trial to monitor the mid- (3 months) and long-term (10 months) adaptive immune response and to docu...
Autores principales: | Calcoen, Bas, Callewaert, Nico, Vandenbulcke, Aline, Kerstens, Winnie, Imbrechts, Maya, Vercruysse, Thomas, Dallmeier, Kai, Van Weyenbergh, Johan, Maes, Piet, Bossuyt, Xavier, Zapf, Dorinja, Dieckmann, Kersten, Callebaut, Kim, Thibaut, Hendrik Jan, Vanhoorelbeke, Karen, De Meyer, Simon F., Maes, Wim, Geukens, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228150/ https://www.ncbi.nlm.nih.gov/pubmed/35746728 http://dx.doi.org/10.3390/v14061257 |
Ejemplares similares
-
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
por: Imbrechts, Maya, et al.
Publicado: (2022) -
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
por: Decru, Bram, et al.
Publicado: (2022) -
Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workers
por: Decru, Bram, et al.
Publicado: (2022) -
The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273
por: Markewitz, Robert, et al.
Publicado: (2022) -
Complementarity determining regions in SARS-CoV-2 hybrid immunity
por: Frans, Glynis, et al.
Publicado: (2023)